SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
6.60
-0.37 (-5.31%)
Jun 23, 2026, 12:58 PM EDT - Market open
SciSparc Employees
SciSparc had 3 employees as of December 31, 2025. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
$285,333
Profits / Employee
-$4,059,667
Market Cap
3.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 1 | 50.00% |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| FibroBiologics | 15 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| 60 Degrees Pharmaceuticals | 3 |
| Matinas BioPharma Holdings | 2 |
SPRC News
- 19 days ago - SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum - GlobeNewsWire
- 19 days ago - Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - TheNewswire
- 26 days ago - SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - GlobeNewsWire
- 4 weeks ago - Neurothera Labs Announces Adoption of Semi-Annual Reporting - TheNewswire
- 7 weeks ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 2 months ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 3 months ago - SciSparc discloses patent application for depression yherapy - TheFly
- 3 months ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire